Talon:

Very good, thank you. The timing and location of the trials are ideal. Moreover, the circumstances involving Biogen and Anavex support what you say about Anavex being Biogen’s hope, most likely, or worst nightmare, not likely because they will do some sort of a deal if Anavex continues to demonstrate what Ariana says it has helped Anavex to do. Ariana Pharma helps ANAVEX® demonstrate efficacy of its Alzheimer’s therapy in phase IIa clinical trial. http://www.arianapharma.com/2018/09/alzheimer-precision-medicine/